ROBERTS GLORE & CO INC /IL/ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROBERTS GLORE & CO INC /IL/ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,698,617
-0.5%
16,676
-1.5%
0.56%
+2.7%
Q2 2023$1,708,003
+9.5%
16,926
-0.2%
0.55%
+4.6%
Q1 2023$1,560,504
+0.8%
16,962
-0.6%
0.52%
-2.8%
Q4 2022$1,547,865
+22.1%
17,062
+2.3%
0.54%
+18.5%
Q3 2022$1,268,000
-10.1%
16,6820.0%0.45%
-3.4%
Q2 2022$1,410,000
-3.0%
16,682
+0.7%
0.47%
+11.9%
Q1 2022$1,454,000
+0.9%
16,570
+0.6%
0.42%
+10.6%
Q4 2021$1,441,000
+4.3%
16,470
-2.6%
0.38%
-9.8%
Q3 2021$1,382,000
-10.1%
16,903
+0.3%
0.42%
-8.7%
Q2 2021$1,538,000
+6.1%
16,853
-0.6%
0.46%
+1.5%
Q1 2021$1,449,000
-10.8%
16,953
-1.5%
0.45%
-14.7%
Q4 2020$1,625,000
+8.5%
17,215
-0.1%
0.53%
-0.6%
Q3 2020$1,498,000
-0.6%
17,237
-0.1%
0.53%
-9.5%
Q2 2020$1,507,000
+2.9%
17,257
-2.8%
0.59%
-5.8%
Q1 2020$1,464,000
-12.9%
17,7570.0%0.63%
-2.5%
Q4 2019$1,681,000
+69.5%
17,757
+55.5%
0.64%
+5.8%
Q3 2019$992,000
-4.8%
11,4160.0%0.61%
-4.6%
Q2 2019$1,042,000
-5.6%
11,416
-0.6%
0.64%
-8.0%
Q1 2019$1,104,000
+7.8%
11,483
-3.8%
0.69%
-4.3%
Q4 2018$1,024,000
-4.7%
11,933
-4.2%
0.72%
+17.4%
Q3 2018$1,074,000
+15.7%
12,462
+1.5%
0.62%
+8.7%
Q2 2018$928,000
-8.0%
12,280
-1.6%
0.57%
-9.1%
Q1 2018$1,009,000
-4.3%
12,480
-0.6%
0.62%
-3.3%
Q4 2017$1,054,000
-5.2%
12,555
-3.1%
0.64%
-10.4%
Q3 2017$1,112,000
+4.9%
12,955
+2.0%
0.72%
+1.7%
Q2 2017$1,060,000
+13.9%
12,705
+1.3%
0.71%
+10.3%
Q1 2017$931,000
-4.2%
12,540
-6.0%
0.64%
-5.5%
Q4 2016$972,000
-5.3%
13,340
+2.7%
0.68%
-8.0%
Q3 2016$1,026,000
-4.8%
12,990
-0.6%
0.74%
-9.8%
Q2 2016$1,078,000
+15.7%
13,065
+1.6%
0.82%
+15.9%
Q1 2016$932,000
-11.7%
12,865
+4.9%
0.70%
-11.7%
Q4 2015$1,055,000
-7.0%
12,265
-0.6%
0.80%
-9.8%
Q3 2015$1,134,000
-10.2%
12,340
-3.9%
0.88%
+0.2%
Q2 2015$1,263,000
-1.6%
12,840
-1.4%
0.88%
-0.5%
Q1 2015$1,284,000
-18.1%
13,020
-23.1%
0.89%
-15.2%
Q4 2014$1,568,000
-1.8%
16,925
-0.2%
1.05%
-5.3%
Q3 2014$1,597,000
+3.8%
16,965
-0.2%
1.10%
+5.9%
Q2 2014$1,539,000
+3.4%
17,000
-2.9%
1.04%
+1.6%
Q1 2014$1,488,000
-3.3%
17,500
-8.6%
1.03%
-3.7%
Q4 2013$1,539,000
+6.3%
19,150
+1.5%
1.07%
-0.3%
Q3 2013$1,448,000
-22.2%
18,875
-28.3%
1.07%
-6.7%
Q2 2013$1,861,00026,3151.15%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders